glp-1 sglt2 combination Illustration of potential synergistic effects of inhibitor with glp 1 agonists and sglt2

Review article: Clinical manifestations and outcomes of chronic nitrous oxide misuse: A systematic review

These data implied that short-term IGF-1 treatment did not alter oxidative stress-induced hepatocyte premature senescence

This definition underscores the connection between ferroptosis and lipid peroxide overload, framing it as a regulated mode of cell death

Offering a modern weight loss benefit especially one that reduces medication dependency gives employers a way to reduce high-cost chronic condition claims, improve productivity and morale, attract and retain health-conscious talent, and address a root cause of rising healthcare costs

To view or add a comment, sign in Recent clinical guidance now recognizes GLP-1 therapies like semaglutide (and in select cases tirzepatide) as first-line options in obesity care, a meaningful step for evidence-based treatment that extends beyond weight loss to cardiovascular protection